Minimally invasive surgery plus steroid for deep brain bleeding
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares removing the brain bleed with a small camera-guided surgery plus giving a steroid medication (methylprednisolone) to reduce swelling, versus standard care. It aims to improve recovery after a specific type of stroke in the basal ganglia region.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 80 years old.
- You have bleeding in a deep area of the brain called the basal ganglia, confirmed by a CT scan.
- The bleeding size needs to be moderate to large (about 2 to 5 tablespoons), but the brain's centerline should not be pushed too far.
- You must be able to start treatment within 24 hours of symptoms starting.
- You need to have noticeable stroke symptoms (like weakness or trouble speaking), but not be in a coma.
- You must be independent in daily activities before this stroke.
- You cannot have bleeding caused by an aneurysm, tumor, or trauma, and you cannot have a blood clotting problem.
- You cannot be on long-term blood thinners or have had a recent heart attack or serious organ disease.
- You must sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether removing the brain bleed with a small camera-guided surgery and giving a steroid medicine early can help people recover better. It is for people who have had a bleed in the outer part of the brain within the last day.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
This trial tests whether removing a certain type of brain bleed (intracerebral hemorrhage) very early, using a minimally invasive surgery approach, improves outcomes compared with standard treatment. It may help people whose bleed is large enough and who can have surgery within a strict time window.
This trial tests a minimally invasive surgery to remove blood from the brain in people who had a bleeding stroke. It aims to see if doing this quickly can help patients recover better.
This trial tests a type of keyhole surgery called neuroendoscopic surgery to remove large blood clots in the brain. It may help people who have had a serious brain bleed and need urgent surgery.
This study tests whether a minimally invasive surgery can safely remove a deep brain bleed (intracerebral hemorrhage) to improve recovery. It aims to see if this gentler approach helps people with moderate-sized bleeds do better than standard care.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.